Health Economics
Competition for scarce health care dollars is fierce. More and more, pharmaceutical and biotech companies must demonstrate their product's value for money in the marketplace.Innomar specializes in synthesizing health economic solutions that integrate clinical and economic outcomes to demonstrate a product's value, identify keys issues, strengthen submission processes, and support policy decisions. Innomar focuses on developing strategic, accurate and actionable analyses - from simple cost minimization analyses to complex predictive decision-tree based models, Innomar provides clear results.
Innomar's Health Economics services include:
- Cost Analyses (e.g. effectiveness/utility)
- Burden of Illness
- Budget Impact Analyses
- Predictive Models
- International Reimbursement Dossiers
- Pricing Submissions and Justification
- Feasibility Studies
- Pricing Optimization and Reimbursement Strategies